BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A
106 results:

  • 1. Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients.
    Kleef R; Dank M; Herold M; Agoston EI; Lohinszky J; Martinek E; Herold Z; Szasz AM
    Sci Rep; 2023 Nov; 13(1):20360. PubMed ID: 37990076
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. KRAS, MYC, and ARF6: inseparable relationships cooperatively promote cancer malignancy and immune evasion.
    Sabe H
    Cell Commun Signal; 2023 May; 21(1):106. PubMed ID: 37158894
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circulating IgG antibodies to periodontal bacteria and lung cancer risk in the CLUE cohorts.
    Ampomah NK; Teles F; Martin LM; Lu J; Koestler DC; Kelsey KT; Beck JD; Platz EA; Michaud DS
    JNCI Cancer Spectr; 2023 May; 7(3):. PubMed ID: 37040077
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
    Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
    Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy.
    Hüttner FJ; Klotz R; Ulrich A; Büchler MW; Probst P; Diener MK
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD011862. PubMed ID: 35014692
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma.
    Li B; Shen S; You S; Zhang G; Gao S; Shi X; Wang H; Yin X; Xu X; Guo S; Jin G
    BMC Cancer; 2021 May; 21(1):612. PubMed ID: 34034684
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eif4a inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer.
    Hashimoto A; Handa H; Hata S; Tsutaho A; Yoshida T; Hirano S; Hashimoto S; Sabe H
    Cell Commun Signal; 2021 May; 19(1):54. PubMed ID: 34001163
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development and validation of a simple-to-use nomogram to predict liver metastasis in patients with pancreatic neuroendocrine neoplasms: a large cohort study.
    Pan M; Yang Y; Teng T; Lu F; Chen Y; Huang H
    BMC Gastroenterol; 2021 Mar; 21(1):101. PubMed ID: 33663420
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeting eif4a-Dependent Translation of KRAS Signaling Molecules.
    Singh K; Lin J; Lecomte N; Mohan P; Gokce A; Sanghvi VR; Jiang M; Grbovic-Huezo O; Burčul A; Stark SG; Romesser PB; Chang Q; Melchor JP; Beyer RK; Duggan M; Fukase Y; Yang G; Ouerfelli O; Viale A; de Stanchina E; Stamford AW; Meinke PT; Rätsch G; Leach SD; Ouyang Z; Wendel HG
    Cancer Res; 2021 Apr; 81(8):2002-2014. PubMed ID: 33632898
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Helicobacter pylori eradication for the prevention of gastric neoplasia.
    Ford AC; Yuan Y; Forman D; Hunt R; Moayyedi P
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD005583. PubMed ID: 32628791
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Extended liver surgery for gallbladder cancer revisited: Is there a role for hepatopancreatoduodenectomy?
    Torres OJM; Alikhanov R; Li J; Serrablo A; Chan AC; de Souza M Fernandes E
    Int J Surg; 2020 Oct; 82S():82-86. PubMed ID: 32535266
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. eif4a supports an oncogenic translation program in pancreatic ductal adenocarcinoma.
    Chan K; Robert F; Oertlin C; Kapeller-Libermann D; Avizonis D; Gutierrez J; Handly-Santana A; Doubrovin M; Park J; Schoepfer C; Da Silva B; Yao M; Gorton F; Shi J; Thomas CJ; Brown LE; Porco JA; Pollak M; Larsson O; Pelletier J; Chio IIC
    Nat Commun; 2019 Nov; 10(1):5151. PubMed ID: 31723131
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. eif4a inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer.
    Müller D; Shin S; Goullet de Rugy T; Samain R; Baer R; Strehaiano M; Masvidal-Sanz L; Guillermet-Guibert J; Jean C; Tsukumo Y; Sonenberg N; Marion F; Guilbaud N; Hoffmann JS; Larsson O; Bousquet C; Pyronnet S; Martineau Y
    JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31672935
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Association Between Body Mass Index and pancreatic cancer: Variation by Age at Body Mass Index Assessment.
    Jacobs EJ; Newton CC; Patel AV; Stevens VL; Islami F; Flanders WD; Gapstur SM
    Am J Epidemiol; 2020 Feb; 189(2):108-115. PubMed ID: 31602476
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ARF6 and AMAP1 are major targets of
    Hashimoto S; Furukawa S; Hashimoto A; Tsutaho A; Fukao A; Sakamura Y; Parajuli G; Onodera Y; Otsuka Y; Handa H; Oikawa T; Hata S; Nishikawa Y; Mizukami Y; Kodama Y; Murakami M; Fujiwara T; Hirano S; Sabe H
    Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17450-17459. PubMed ID: 31399545
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning pancreatic Neuroendocrine Tumors.
    Ye H; Xu HL; Shen Q; Zheng Q; Chen P
    J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eif4a1 and eIF4E.
    Ma X; Li B; Liu J; Fu Y; Luo Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
    Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
    BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
    Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
    Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Associations of Dietary Antioxidants and Risk of Type 2 Diabetes: Data from the 2007-2012 Korea National Health and Nutrition Examination Survey.
    Quansah DY; Ha K; Jun S; Kim SA; Shin S; Wie GA; Joung H
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28981464
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.